Master PathAI with our step-by-step tutorial, detailed feature walkthrough, and expert tips.
Request a PathAI sales consultation, confirm AISight or AISight Dx fit, review scanner and workflow compatibility, scope AI product access or biopharma services, and validate regulatory intended use before deployment.
💡 Quick Start: Follow these 1 steps in order to get up and running with PathAI quickly.
Explore the key features that make PathAI powerful for automation & workflows workflows.
Cloud-native enterprise workflow system that centralizes case management, whole-slide image management, and access to AI applications for anatomic pathology laboratories.
Large hospital pathology departments or reference labs moving from glass-slide workflows toward digital review, remote collaboration, and centralized image management.
FDA-cleared digital pathology image management system for primary diagnosis in the United States under specified scanner and workflow conditions, with CE-IVD marking for primary diagnosis in the EEA, UK, and Switzerland.
Clinical laboratories evaluating a regulated digital pathology platform for eligible primary diagnosis workflows with supported scanners and validated operating procedures.
AI-assisted biomarker analysis products for tissue samples in research and biopharma workflows, with individual product use depending on regulatory status, indication, assay, and geography.
Pharma companies running oncology or inflammatory disease studies that need consistent PD-L1, HER2, ER, PR, Ki-67, or other pathology-based measurements across trial sites.
Network-oriented program intended to connect pathology laboratories with PathAI's digital pathology and AI ecosystem, including possible support for biopharma evidence generation and access to AI tools.
Pathology organizations exploring participation in a digital pathology network while assessing data governance, commercial terms, and operational requirements.
Pathology services and AI-enabled analysis support for clinical trial sponsors, including tissue workflows, histology assessment, slide digitization, and endpoint standardization where applicable.
Biopharma companies outsourcing pathology workflows for clinical studies that require coordinated sample handling, slide review, and standardized histopathology analysis.
PathAI is used for AI-powered digital pathology workflows, including image management, case management, biomarker analysis, clinical trial histology assessment, tumor microenvironment analysis, and AI-assisted pathology research.
PathAI states that AISight Dx, its digital pathology image management system, is FDA-cleared for primary diagnosis in the United States. Many individual PathAI algorithms are listed as Research Use Only in the United States and not for diagnostic procedures.
PathAI is best suited for anatomic pathology laboratories, academic medical centers, reference laboratories, health systems, central labs, and biopharma companies working on biomarker discovery, clinical trials, or digital pathology transformation.
No public self-serve pricing is listed on the website. PathAI uses enterprise pricing based on deployment needs, platform scope, AI products, services, and clinical trial or laboratory requirements. Buyers need to request a quote from PathAI sales for exact contract pricing.
The website presents PathAI as AI-powered pathology technology intended to support pathology workflows, improve histology assessment, and assist research or clinical trial processes. It does not describe the platform as replacing pathologists.
Now that you know how to use PathAI, it's time to put this knowledge into practice.
Sign up and follow the tutorial steps
Check pros, cons, and user feedback
See how it stacks against alternatives
Follow our tutorial and master this powerful automation & workflows tool in minutes.
Tutorial updated March 2026